KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Change in Receivables (2019 - 2025)

Historic Change in Receivables for Co-Diagnostics (CODX) over the last 7 years, with Q3 2025 value amounting to -$164190.0.

  • Co-Diagnostics' Change in Receivables rose 4933.27% to -$164190.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$168010.0, marking a year-over-year increase of 6709.38%. This contributed to the annual value of -$186391.0 for FY2024, which is 9265.31% up from last year.
  • According to the latest figures from Q3 2025, Co-Diagnostics' Change in Receivables is -$164190.0, which was up 4933.27% from $57186.0 recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Change in Receivables ranged from a high of $6.1 million in Q4 2021 and a low of -$9.4 million during Q2 2022
  • Moreover, its 5-year median value for Change in Receivables was -$68970.0 (2024), whereas its average is -$473999.7.
  • Data for Co-Diagnostics' Change in Receivables shows a peak YoY increase of 135195.02% (in 2022) and a maximum YoY decrease of 143524.57% (in 2022) over the last 5 years.
  • Over the past 5 years, Co-Diagnostics' Change in Receivables (Quarter) stood at $6.1 million in 2021, then plummeted by 138.89% to -$2.4 million in 2022, then skyrocketed by 83.52% to -$393151.0 in 2023, then soared by 82.46% to -$68970.0 in 2024, then plummeted by 138.06% to -$164190.0 in 2025.
  • Its Change in Receivables was -$164190.0 in Q3 2025, compared to $57186.0 in Q2 2025 and $7964.0 in Q1 2025.